SWISS PHARMACEUTICAL WHOLESALER . IMPORT AND EXPORT OF MEDICINAL PRODUCTS . INTERNATIONAL PHARMACEUTICAL TRADING
ENJAYMO
ENJAYMO (sutimlimab-jome) is indicated to decrease the need for red blood cell (RBC) transfusion due to hemolysis in adults with cold agglutinin disease.
